✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Catalyst Pharmaceuticals Inc

Common Name
Catalyst Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
182
Ticker
CPRX
Exchange
NASDAQ CAPITAL MARKET
Description
Catalyst Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-tr...

Catalyst Pharmaceuticals's Revenues Data

Explore Catalyst Pharmaceuticals's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2024202320222021-2019
Total Revenue(USD)
491,734,000a
398,204,000a
214,203,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Catalyst Pharmaceuticals’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Catalyst Pharmaceuticals's 10-K 2024